The Role of Testing in Determining Suitability of Donors and Tissues

Tissue and Cell Donation: An Essential Guide

Volumn , Issue , 2009, Pages 116-133

  Grossi, Paolo ^a,b   Strong, Michael ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b Italian National Transplant Centre   (Italy)

^c PUGET SOUND BLOOD CENTER   (United States)

Author keywords

European association of tissue banks (EATB); Eye bank associations of america and of europe (EBAA and EEBA); Hemodilution of donor blood sample; Incidence window period model; Quality of deceased donor blood samples; Role of testing in determining suitability of donors and tissues; Sample and donor identification issues; Stored blood samples for future viral testing; Testing requirements set by professional organizations american association of tissue banks (AATB); Tissue transplantation therapy

Indexed keywords

EID: 84889353270     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444306262.ch6     Document Type: Chapter

References (28)

1. Eastlund T, Strong DM. Infectious disease transmission through tissue transplantation. In: Phillips GO, editor. Advances Tissue Banking, Volume 7. Singapore: World Scientifi c; 2004. p. 51-131.
2. Pearson KA, Brubaker SA, editors. Standards for Tissue Banking, 11th edition. McLean, VA: American Association of Tissue Banks; 2006.
3. Eye Bank Association of America. EBAA Medical Standards. Washington, DC: EBAA; 2002. https://www.eyebankassociation.org/eweb/docs/members/standards/ medstandards1106.pdf (accessed January 25, 2007).
4. European Association of Tissue Banking. Common standards for tissue and cell banking. http://www.eatb.de/html/standards.htm (accessed January 5, 2007).
5. US Food and Drug Administration. Guidance for Industry. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). http://www.fda.gov/cber/gdlns/tissdonor.htm (accessed January 5, 2007).
6. US Food and Drug Administration. Guidance for industry: donor screening for antibodies to HTLV-II. August 1997. http://www.fda.gov/cber/guidelines.htm (accessed January 5, 2007).
7. National Standards for Cells, Tissues and Organs for Transplantation and Assisted Reproduction. Canadian Standards Association, National Standards of Canada CAN/ CSA-Z900.1 (general standards) and CAN/CSA-2900.2.2 (tissue standards). http://canadagazette.gc.ca/index-e.html (accessed January 5, 2007).
8. Commission Directive 2006/17/EC. Implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Offi cial Journal of the European Union. 2006 Feb 9.
9. Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notifi cation of serious adverse reactions and events, and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Offi cial Journal of the European Union L. 2006 Oct 25;294/32.
10. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards for quality and safety in the donation, procurement, processing, preservation, storage and distribution of human tissues and cells. Offi cial Journal of the European Union L. 2004 Apr 7;102/48.
11. Australian Code of Good Manufacturing Practice-Human Blood and Tissues. http://www.tga.gov.au (accessed January 5, 2007).
12. Zou S, Dodd RY, Stramer SL, Strong DM for the Tissue Safety Study Group. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351(8):751-9.
13. Conrad EU, Gretch D, Obermeyer K, Moogk M, Sayers M, Wilson J, et al. The transmission of hepatitis C virus by tissue transplantation. J Bone Joint Surg. 1995;77-A(2):214-24.
14. Eastlund T, Tomford W. The effect of long term frozen storage and freeze thaws on tissue donor serum infectious disease test performance. Tissue Cell Rep. 1995;2(1):18-19.
15. Busch MP, Wilbur JC, Johnson P, Tobler L, Evans CS. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion. 1992;32(5): 420-5.
16. José M, Gajardo R, Jorquera JI. Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples under long-term storage. Biologicals. 2005;33(1):9-16.
17. Sanzen L, Carlsson A. (1997) Transmission of human T-cell lymphotrophic virustype I by a deep-frozen bone allograft. Acta Orthop Scand. 1997;68(1):72-4.
18. Warwick RM, Eglin R. Should deceased donors be tested for vCJD? Cell Tissue Bank. 2005;6(4):263-70.
19. Eastlund T. Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank. 2006;7(3):147-66.
20. American Association of Tissue Banks. Guidance Document No 2; Prevention of contamination and cross-contamination at recovery: practices and culture results. http://aatb.timberlakepublishing.com/files/2007bulletin46attachment1.pdf (accessed January 6, 2007).
21. Warwick RM, Magee JG, Leeming JP, Graham JC, Hannan MM, Chadwick M, et al. Mycobacteria and allograft heart valve banking: an international survey. J Hosp Infect. 2008;68(3):255-61.
22. Heim A, Wagner D, Rothamel T, Hartmann V, Flik J, Verhagen W, et al. Evaluation of serological screening of cadaveric sera for donor selection for cornea transplantation J Med Virol. 1999;58(3):291-5.
23. Padley DJ, Lucas SB, Saldanha J. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens. Transplantation. 2003;76(2):432-4.
24. Strong DM, Nelson K, Pierce M, Stramer SL. Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid. Cell Tissue Bank. 2005;6(4):255-62.
25. Guidelines for the blood transfusion services in the United Kingdom http://www.transfusionguidelines.org.uk (accessed January 16, 2008).
26. US Food and Drug Administration. Donor screening tests for testing HCT/P donors. http://www.fda.gov/cber/tissue/prod.htm (accessed January 16, 2008).
27. Eastlund T. Hemodilution due to blood loss and transfusion and reliability of cadaver tissue donor infectious disease testing. Cell Tissue Bank. 2000;1(2):121-7.
28. Warwick RM, Rushambuza FG, Brown J, Patel R, Tabb S, Poniatowski S, et al. Confi rmation of cadaveric blood sample identity by DNA profi ling using STR (short tandem repeat) analysis. Cell Tissue Bank. 2008;9:323-8.